Portfolio (Quarterly)
Guide ↗
PSP Research LLC
· CIK 0002106939| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | — | PRAXIS PRECISION MEDICINES I | — | 1,500.0 | $483K | 0.34% | -482.0 | -24.3% | $322.19 | — |
| 22 | AXSM | AXSOME THERAPEUTICS INC. | Healthcare | 2,845.0 | $481K | 0.34% | NEW | — | $169.02 | +38.2% |
| 23 | — | NEWAMSTERDAM PHARMA COMPANY | — | 15,000.0 | $480K | 0.34% | +80.0 | +0.5% | $32.01 | — |
| 24 | ARDX | ARDELYX INC | Healthcare | 80,000.0 | $479K | 0.34% | NEW | — | $5.99 | +6.0% |
| 25 | IMVT | IMMUNOVANT INC | Healthcare | 19,200.0 | $477K | 0.34% | -1K | -5.4% | $24.84 | +37.4% |
| 26 | ARGX | ARGENX SE | Healthcare | 641.0 | $468K | 0.33% | +11.0 | +1.8% | $730.25 | +11.8% |
| 27 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 20,000.0 | $467K | 0.33% | -5K | -19.1% | $23.36 | -13.8% |
| 28 | — | INHIBRX BIOSCIENCES INC | — | 6,927.0 | $466K | 0.33% | +538.0 | +8.4% | $67.23 | — |
| 29 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 19,700.0 | $464K | 0.33% | +984.0 | +5.3% | $23.56 | -10.8% |
| 30 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 22,100.0 | $463K | 0.33% | NEW | — | $20.95 | +11.6% |
| 31 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 5,000.0 | $462K | 0.33% | -2K | -27.1% | $92.38 | +9.0% |
| 32 | COGT | COGENT BIOSCIENCES INC | Healthcare | 12,000.0 | $462K | 0.33% | -1K | -9.3% | $38.49 | -15.4% |
| 33 | GLUE | MONTE ROSA THERAPEUTICS INC | Healthcare | 28,000.0 | $461K | 0.33% | NEW | — | $16.45 | +14.8% |
| 34 | IMCR | IMMUNOCORE HLDGS PLC | Healthcare | 15,141.0 | $457K | 0.32% | +717.0 | +5.0% | $30.15 | -0.5% |
| 35 | CRSP | CRISPR THERAPEUTICS AG | Healthcare | 9,500.0 | $452K | 0.32% | -80.0 | -0.8% | $47.57 | +4.9% |
| 36 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 6,000.0 | $446K | 0.32% | -1K | -16.0% | $74.26 | -5.4% |
| 37 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 28,700.0 | $445K | 0.32% | — | — | $15.50 | +13.1% |
| 38 | AUPH | AURINIA PHARMACEUTICALS INC | Healthcare | 30,000.0 | $445K | 0.32% | -4K | -11.6% | $14.82 | +4.3% |
| 39 | ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | 19,766.0 | $440K | 0.31% | — | — | $22.26 | -4.2% |
| 40 | RAPP | RAPPORT THERAPEUTICS INC | Healthcare | 14,000.0 | $438K | 0.31% | -4K | -20.0% | $31.29 | +14.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%